Translational neuropathic pain research: A clinical perspective

Neuroscience

Volumn 338, Issue , 2016, Pages 27-35

  Bouhassira, D ^a   Attal, N ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

chronic pain; clinical research; translational research; treatment strategies

Indexed keywords

ALFENTANIL; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BOTULINUM TOXIN; CAPSAICIN; CLONIDINE; DULOXETINE; KETAMINE; LIDOCAINE; OXCARBAZEPINE; PREGABALIN;

CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); DIABETIC NEUROPATHY; DRUG EFFICACY; FUNCTIONAL NEUROIMAGING; HUMAN; LASER EVOKED POTENTIAL; META ANALYSIS (TOPIC); MICRONEUROGRAPHY; MULTICENTER STUDY (TOPIC); NEUROGRAPHY; NEUROPATHIC PAIN; NEUROPATHIC PAIN SCALE; NEUROPATHIC PAIN SYMPTOM INVENTORY; PAIN ASSESSMENT; PHARMACEUTICAL CARE; PRIORITY JOURNAL; QUANTITATIVE SENSORY TESTING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STUDY DESIGN; TRANSLATIONAL RESEARCH; VISUAL ANALOG SCALE; ANIMAL; NEURALGIA; PATHOPHYSIOLOGY; PROCEDURES;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; NEURALGIA; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84962275378     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2016.03.029     Document Type: Review

References (64)

1. Attal, N., Guirimand, F., Brasseur, L., Gaude, V., Chauvin, M., Bouhassira, D., Effects of IV morphine in central pain: a randomized placebo-controlled study. Neurology 58:4 (2002), 554–563.
2. Attal, N., Rouaud, J., Brasseur, L., Chauvin, M., Bouhassira, D., Systemic lidocaine in pain due to peripheral nerve injury and predictors of response. Neurology 62:2 (2004), 218–225.
3. Attal, N., Fermanian, C., Fermanian, J., Lanteri-Minet, M., Alchaar, H., Bouhassira, D., Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion?. Pain 138:2 (2008), 343–353.
4. Attal, N., Bouhassira, D., Baron, R., Dostrovsky, J., Dworkin, R.H., Finnerup, N., et al. Assessing symptom profiles in neuropathic pain clinical trials: can it improve outcome?. Eur J Pain 15:5 (2011), 441–443.
5. Attal, N., Bouhassira, D., Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms?. Pain 156:Suppl 1 (2015), S104–S114.
6. Attal, N., Gaudé, V., Brasseur, L., Dupuy, M., Guirimand, F., Parker, F., Bouhassira, D., Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study. Neurology 54:3 (2000), 564–574.
7. Attal, N., Lanteri-Minet, M., Laurent, B., Fermanian, J., Bouhassira, D., The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain 152:12 (2011), 2836–2843.
8. Attal, N., de Andrade, D.C., Adam, F., Ranoux, D., Teixeira, M.J., Glahardoni, R., Raicher, I., Üceyler, N., Sommer, C., Bouhassira, D., Efficacy and safety of repeated injections of botulinum toxin a in peripheral neuropathic pain and predictors of treatment response: a randomised double blind placebo controlled study. Lancet Neurol, 2016, 10.1016/S1474-4422(16)00017-X (in press).
9. Backonja, M.M., Attal, N., Baron, R., Bouhassira, D., Drangholt, M., Dyck, P.J., et al. Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain 154:9 (2013), 1807–1819.
10. Baron, R., Tolle, T.R., Gockel, U., Brosz, M., Freynhagen, R., A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms. Pain 146:1–2 (2009), 34–40.
11. Baron, R., Binder, A., Wasner, G., Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 9:8 (2010), 807–819.
12. Baron, R., Forster, M., Binder, A., Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach. Lancet Neurol 11:11 (2012), 999–1005.
13. Bennett, M.I., The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 92 (2001), 147–157.
14. Bouhassira, D., Attal, N., Novel strategies for neuropathic pain. Villanueva, L., Dickenson, A., Ollat, H., (eds.) Progress in Pain Research and Management, vol. 31, 2004, IASP Press, 299–310.
15. Bouhassira, D., Attal, N., Diagnosis and assessment of neuropathic pain: the saga of clinical tools. Pain 152:Suppl. 3 (2011), S74–S83.
16. Bouhassira, D., Attal, N., Fermanian, J., Al-Chaar, M., Gautron, M., Boureau, F., Grisart, J., Masquelier, E., Rostaing, S., Collin, E., Lanteri-Minet, M., Development and validation of the Neuropathic Pain Symptom Inventory. Pain 108 (2004), 248–257.
17. Bouhassira, D., Attal, N., Alchaar, H., Boureau, F., Brochet, B., Bruxelle, J., Cunin, G., Fermanian, J., Ginies, P., Grun-Overdyking, A., Jafari-Schluep, H., Lantéri-Minet, M., Laurent, B., Mick, G., Serrie, A., Valade, D., Vicaut, E., Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114 (2005), 29–36.
18. Bouhassira, D., Lantéri-Minet, M., Attal, N., Laurent, B., Touboul, C., Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136:3 (2008), 380–387.
19. Bouhassira, D., Wilhelm, S., Schacht, A., Perrot, S., Kosek, E., Cruccu, G., et al. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind. COMBO-DN study. Pain 155:10 (2014), 2171–2179.
20. Campbell, C.M., Kipnes, M.S., Stouch, B.C., Brady, K.L., Kelly, M., Schmidt, W.K., et al. Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain 153:9 (2012), 1815–1823.
21. Cruccu, G., Sommer, C., Anand, P., Attal, N., Baron, R., Garcia-Larrea, L., et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol 17:8 (2010), 1010–1018.
22. Demant, D.T., Lund, K., Vollert, J., Maier, C., Segerdahl, M., Finnerup, N.B., et al. The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double-blind, placebo-controlled phenotype-stratified study. Pain 155:11 (2014), 2263–2273.
23. Edwards, R.R., Haythornthwaite, J.A., Tella, P., Max, M.B., Raja, S., Basal heat pain thresholds predict opioid analgesia in patients with postherpetic neuralgia. Anesthesiology 104:6 (2006), 1243–1248.
24. Edwards, R.H., Dworkin, R.H., Turk, D.C., Angst, M., Dionne, R., Freeman, R., Hansson, P., Haroutounian, S., Arendt-Nielsen, L., Attal, N., et al. Patient phenotyping in analgesic clinical trials: IMMPACT recommendations. Pain, 2015 (submitted).
25. Elliott, A.M., Smith, B.H., Penny, K.I., Smith, W.C., Chambers, W.A., The epidemiology of chronic pain in the community. Lancet 354:9186 (1999), 1248–1252.
26. Fields, H.L., Rowbotham, M., Baron, R., Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis 5:4 (1998), 209–227.
27. Finnerup, N.B., Baastrup, C., Spinal cord injury pain: mechanisms and management. Curr Pain Headache Rep 16:3 (2012), 207–216.
28. Finnerup, N.B., Sindrup, S.H., Bach, F.W., Johannesen, I.L., Jensen, T.S., Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain 96:3 (2002), 375–383.
29. Finnerup, N.B., Biering-Sørensen, F., Johannesen, I.L., Terkelsen, A.J., Juhl, G.I., Kristensen, A.D., Sindrup, S.H., Bach, F.W., Jensen, T.S., Intravenous lidocaine relieves spinal cord injury pain: a randomized controlled trial. Anesthesiology 102:5 (2005), 1023–1030.
30. Finnerup, N.B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R.H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T.S., Kamerman, P.R., Lund, K., Moore, A., Raja, S.N., Rice, A.S., Rowbotham, M., Sena, E., Siddall, P., Smith, B.H., Wallace, M., Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14 (2015), 162–173.
31. Finnerup, N.B., Haroutounian, S., Kamerman, P., Baron, R., Bennett, D.L.H., Bouhassira, D., Cruccu, G., Freeman, R., Hansson, P., Nurmikko, T., Raja, S.N., Rice, A.S.C., Serra, J., Smith, B.H., Treede, R.D., Jensen, T.S., Neuropathic pain: An updated grading system for research and clinical practice. Pain, 2016 (in press).
32. Foley, P.L., Vesterinen, H.M., Laird, B.J., Sena, E.S., Colvin, L.A., Chandran, S., MacLeod, M.R., Fallon, M.T., Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis. Pain 154:5 (2013), 632–642.
33. Freeman, R., Baron, R., Bouhassira, D., Cabrera, J., Emir, B., Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs. Pain 155:2 (2014), 367–376.
34. Freeman R, Bouhassira D, Baron R, Cabrera J, Parsons B, Yi L, Emir B (submitted for publication) Bedside assessment of neuropathic pain symptoms and signs predict clinical response to pregabalin.
35. Freynhagen, R., Baron, R., Gockel, U., Tölle, T.R., PainDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 22 (2006), 1911–1920.
36. Galer, B.S., Jensen, M.P., Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 48 (1997), 332–338.
37. Garcia-Larrea, L., Peyron, R., Pain matrices and neuropathic pain matrices: a review. Pain 154 (2013), S29–S43.
38. Geber, C., Klein, T., Azad, S., Birklein, F., Gierthmuhlen, J., Huge, V., et al. Test-retest and interobserver reliability of quantitative sensory testing according to the protocol of the German Research Network on Neuropathic Pain (DFNS): a multi-centre study. Pain 152:3 (2011), 548–556.
39. Gottrup, H., Bach, F.W., Juhl, G., Jensen, T.S., Differential effect of ketamine and lidocaine on spontaneous and mechanical evoked pain in patients with nerve injury pain. Anesthesiology 104:3 (2006), 527–536.
40. Haanpaa, M., Attal, N., Backonja, M., Baron, R., Bennett, M., Bouhassira, D., et al. NeuPSIG guidelines on neuropathic pain assessment. Pain 152:1 (2011), 14–27.
41. Hansson, P., Lindblom, U., Hyperalgesia assessed with quantitative sensory testing in patients with neurogenic pain. Willis, W.D., (eds.) Hyperalgesia and Allodynia, 1992, Raven Press, New York, 335–343.
42. Hansson, P., Backonja, M., Bouhassira, D., Usefulness and limitations of quantitative sensory testing: clinical and research application in neuropathic pain states. Pain 129:3 (2007), 256–259.
43. Hatem, S.M., Attal, N., Ducreux, D., Gautron, M., Parker, F., Plaghki, L., Bouhassira, D., Clinical, functional and structural determinants of central pain in syringomyelia. Brain 133:11 (2010), 3409–3422.
44. Klit, H., Finnerup, N.B., Jensen, T.S., Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol 8:9 (2009), 857–868.
45. Leffler, A.S., Hansson, P., Painful traumatic peripheral partial nerve injury-sensory dysfunction profiles comparing outcomes of bedside examination and quantitative sensory testing. Eur J Pain 12:4 (2008), 397–402.
46. Maier, C., Baron, R., Tolle, T.R., Binder, A., Birbaumer, N., Birklein, F., et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 150:3 (2010), 439–450.
47. Mainka, T., Malewicz, N.M., Baron, R., Enax-Krumova, E.K., Treede, R.D., Maier, C., Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain. Eur J Pain 20 (2016), 116–129.
48. Martinez, V., Fletcher, D., Martin, F., Orlikowski, D., Sharshar, T., Chauvin, M., Bouhassira, D., Attal, N., Small fibre impairment predicts neuropathic pain in Guillain-Barré syndrome. Pain 151:1 (2010), 53–60.
49. Moisset, X., Bouhassira, D., Brain imaging of neuropathic pain. NeuroImage 37:Suppl. 1 (2007), S80–S88.
50. Percie du Sert, N., Rice, A.S., Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain. Br J Pharmacol 171:12 (2014), 2951–2963.
51. Pfau, D.B., Krumova, E.K., Treede, R.D., Baron, R., Toelle, T., Birklein, F., et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): reference data for the trunk and application in patients with chronic postherpetic neuralgia. Pain 155:5 (2014), 1002–1015.
52. Ranoux, D., Attal, N., Morain, F., Bouhassira, D., Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol 64:3 (2008), 274–283.
53. Rolke, R., Baron, R., Maier, C., Tolle, T.R., Treede, R.D., Beyer, A., et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 123:3 (2006), 231–243.
54. Schiff, E., Eisenberg, E., Can quantitative sensory testing predict the outcome of epidural steroid injections in sciatica? A preliminary study. Anesth Analg 97:3 (2003), 828–832.
55. Simpson, D.M., Schifitto, G., Clifford, D.B., Murphy, T.K., Durso-De Cruz, E., Glue, P., et al. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology 74:5 (2010), 413–420.
56. Timmerman, H., Heemstra, I., Schalkwijk, A., Verhagen, C., Vissers, K., Engels, Y., Assessment of neuropathic pain in patients with cancer: the interobserver reliability. An observational study in daily practice. Pain Physician 16:6 (2013), 569–580.
57. Torrance, N., Smith, B.H., Bennett, M.I., Lee, A.J., The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 7 (2006), 281–289.
58. Treede, R.D., Jensen, T.S., Campbell, J.N., Cruccu, G., Dostrovsky, J.O., Griffin, J.W., et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70 (2008), 1630–1635.
59. Treede, R.D., Rief, W., Barke, A., Aziz, Q., Bennett, M.I., Benoliel, R., Cohen, M., Evers, S., Finnerup, N.B., First, M.B., Giamberardino, M.A., Kaasa, S., Kosek, E., Lavand'homme, P., Nicholas, M., Perrot, S., Scholz, J., Schug, S., Smith, B.H., Svensson, P., Vlaeyen, J.W., Wang, S.J., A classification of chronic pain for ICD-11. Pain 156:6 (2015), 1003–1007.
60. Truini, A., Padua, L., Biasiotta, A., Caliandro, P., Pazzaglia, C., Galeotti, F., Inghilleri, M., Cruccu, G., Differential involvement of A-delta and A-beta fibres in neuropathic pain related to carpal tunnel syndrome. Pain 145:1–2 (2009), 105–109.
61. Valeriani, M., Pazzaglia, C., Cruccu, G., Truini, A., Clinical usefulness of laser evoked potentials. Neurophysiol Clin 42:5 (2012), 345–353.
62. Wasner, G., Kleinert, A., Binder, A., Schattschneider, J., Baron, R., Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin. J Neurol 252 (2005), 677–686.
63. Woolf, C.J., Max, M.B., Mechanism-based pain diagnosis: issues for analgesic drug development. Anesthesiology 95:1 (2001), 241–249.
64. Woolf, C.J., Bennett, G.J., Doherty, M., Dubner, R., Kidd, B., Koltzenburg, M., Lipton, R., Loeser, J.D., Payne, R., Torebjork, E., Towards a mechanism-based classification of pain?. Pain 77:3 (1998), 227–229.